Evaluation of a collagen cell carrier for urethral reconstructive surgery using a biological simulation model

by S. Aufderklamm, A. Stenzl, B. Amend
Published 2020-07-01

Reconstructive urology

by K.D. Sievert, B. Winter, A. Stenzl
Published 2006-10-01

KEYNOTE-641 phase 3 study of pembrolizumab plus enzalutamide versus placebo plus enzalutamide for metastatic castration-resistant prostate cancer

by A. Stenzl, J. Burgents, L.W. Liang, J.N. Graff
Published 2020-07-01

Cytology-based photodynamic detection of bladder cancer cells in voided urine

by Y. Nakai, S. Aufderklamm, N. Harland, J. Johaenning, K. Fujimoto, Y. Hirao, A. Stenzl
Published 2020-07-01

Expression of immune checkpoint ligand CD276 (B7-H3) is regulated in urothelial carcinoma on a transcriptional and post-transcriptional level and drops significantly in late stage...

by W. Aicher, F.B. Maurer, L. Reitnauer, M. Korn, M. Maas, J. Hennenlotter, T. Todenhöfer, A. Stenzl
Published 2020-07-01

Laparoscopic radical nephrectomy with inferior vena cava thrombectomy: highlight of key surgical steps

by A. Sim, T. Todenhöfer, J. Mischinger, O. Fahmy, J. Boettge, S. Rausch, S. Bier, S. Aufderklamm, A. Stenzl, G. Gakis, C. Schwentner

Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma

by Wilhelm K. Aicher, M. Korn, L. Reitnauer, F. B. Maurer, J. Hennenlotter, P. C. Black, T. Todenhofer, J. Bedke, A. Stenzl
Published 2021-04-01

Prostate cancer and diabetes mellitus - indications for an association between glucose metabolism and androgen receptor signalling

by T. Todenhöfer, G.I. Russo, G. Morgia, G. Broggi, R. Caltabiano, J. Hennenlotter, U. Kühs, S.Z. Lutz, A. Stenzl, M. Heni
Published 2020-07-01

Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled tria...

by A Stenzl, H Penkoff, E Dajc-Sommerer, A Zumbraegel, L Hoeltl, M Scholz, C Riedl, J Bugelnig, A Hobisch, M Burger, G Mikuz, U Pichlmeier
Published 2011-10-01

ARCHES: Efficacy of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC) by prior local and systemic...

by A. Stenzl, R.Z. Szmulewitz, D. Petrylak, J. Holzbeierlein, A. Villers, A. Azad, A. Alcaraz, B. Alekseev, T. Iguchi, N.D. Shore, F. Gomez-Veiga, B. Rosbrook, B. Baron, G.P. Haas, A. Armstrong
Published 2020-07-01